| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 19.64M | $ 22.31M | $ 17.00K | $ 16.00K | $ 15.00K |
| Operating Income | $ -15.68M | $ -56.61M | $ -83.54M | $ -107.09M | $ -77.15M |
| EBITDA | $ -20.07M | $ -51.16M | $ -83.90M | $ -110.20M | $ -76.65M |
| Net Income | $ -29.88M | $ -52.98M | $ -81.95M | $ -113.48M | $ -77.26M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 16.54M | $ 64.54M | $ 65.45M | $ 103.94M | $ 167.44M |
| Total Debt | $ 3.03M | $ 14.62M | $ 26.95M | $ 27.08M | $ 2.71M |
| Net Debt | $ -5.37M | $ -40.12M | $ -4.24M | $ -42.29M | $ -135.93M |
| Total Liabilities | $ 8.06M | $ 50.91M | $ 88.02M | $ 80.40M | $ 39.51M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -23.14M | $ -50.44M | $ -74.00M | $ -97.28M | $ -64.13M |
| Operating Cash Flow | $ -23.15M | $ -50.42M | $ -74.00M | $ -92.24M | $ -63.94M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
ObsEva (OBSEF)
OTHER OTC:OBSEF
